Global Tendonitis Treatment Market Analysis Report 2023-2028 Featuring Merck and Co, Bayer, AstraZeneca, Boehringer Ingelheim, Abbott Laboratories, Pfizer, GlaxoSmithKline, & Almatica Pharma


Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "Tendonitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Therapy (Therapy v/s Surgery), By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others), By Region and Competition" report has been added to ResearchAndMarkets.com's offering.

Global Tendonitis Treatment Market is anticipated to witness impressive growth to 2028

The growing demand for the best treatment with a low cost, along with increasing awareness about new therapies such as joint manipulation and physical therapy, will significantly increase the demand for the tendonitis treatment market across different parts of the globe.

Additionally, the growing improvement of healthcare infrastructure for the treatment of bone disorders across the globe is further expected to increase the demand for tendonitis treatment, thereby fuelling market growth through 2027. Besides growing awareness about maintaining a healthy lifestyle, people are looking for sports activities which will further be expected to support the tendonitis treatment market growth during the forecast period.

Furthermore, an increased number of sport-related injuries due to either trauma or overuse of muscles or joints, improper rehabilitation, and imbalanced training sessions are further expected to increase the demand for tendonitis treatment, thereby supporting market growth. According to the National Safety Council (NSC), in 2021, exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation.

Increased Number of Sport-Related Injuries

The rapid increase in sport-related activities causing sport-related injuries is expected to create lucrative growth during the forecast period. Sports injuries can cause soft tissue injuries, which can be a major market driver across the globe.

The number of people choosing sports as their career or hobby and getting work opportunities in the field of sports has increased. Achilles tendinopathy affects 40% to 50% of competitive runners, according to a study by sports medicine experts from the University of Virginia and Duke University.

Tendonitis is becoming more common day by day in the population, and 5-10 cases per 100,000 population get affected, which is expected to boost the market during the forecast period. Similarly, the number of patients are demanding physical therapy and minimally invasive surgeries, which will propel the market growth during the forecast period.

Stryker has launched the Citrelock Tendon Fixation Device system at the American Orthopaedic Foot and Ankle Society (AOFAS) annual meeting, which was held from 22-25 September 2021 in Charlotte, North Carolina, US, and designed to enable fixation without causing damage to the tendon during placement.

Growing Aging Population

Different types of chronic disorders are affecting people across the globe. In Tendonitis, a thick fibrous cord that connects muscle and bone becomes infected. The growing cases of Tendonitis, majorly among the aging population, are expected to enhance the demand for tendonitis treatment and boost the market growth during the forecast period.

There are an estimated 32.0 million tendon injuries reported each year on average across the globe. So, most of the patients who are injured due to accidents demand physical therapy, over-the-counter pain relievers, and surgical procedures, which will further propel the market growth during the forecast period. Eccentric strengthening is the main treatment for tendon disorders, so physical therapy is the first line of treatment for tendonitis, which will boost the market growth during the forecast period.

These are the major factor in the growth of the global Tendonitis Treatment Market in the forecast period. Every year in the U.S., about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries each year due to sports injuries will enhance the demand for tendonitis treatment. According to the National Safety Council (NSC), in 2021, exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation.

Competitive landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tendonitis Treatment Market.

  • Merck and Co. Inc.
  • Bayer AG
  • AstraZeneca Plc.
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Abbott Laboratories, Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Almatica Pharma, Inc.

Report Scope:

Tendonitis Treatment Market, By Therapy:

  • Therapy
  • Surgery

Tendonitis Treatment Market, By Condition:

  • Tennis Elbow
  • Golfer's Elbow
  • Pitcher's Elbow
  • Jumper's Knee
  • Others

Tendonitis Treatment Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

For more information about this report visit https://www.researchandmarkets.com/r/7344ln

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data